BridgeBio Oncology Therapeutics, Inc. (BBOT)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 1 signal for BridgeBio Oncology Therapeutics, Inc.. Most notable: 2026-06-22: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-21 | Cobo Marc | officer | F | 203 | 2.68 | $544 |
| 2026-10-01 | Ben Yong | officer | F | 1,047 | 3.94 | $4,125 |
| 2026-10-01 | Beltran Pedro | director | F | 1,047 | 3.94 | $4,125 |
| 2026-10-01 | Elmelech Idan | officer | F | 343 | 3.94 | $1,351 |
| 2026-10-01 | Cobo Marc | officer | F | 126 | 3.94 | $496 |
| 2026-09-10 | Cobo Marc | officer | F | 203 | 5.52 | $1,121 |
| 2026-09-10 | Cobo Marc | officer | A | 9,038 | 0 | $0 |
| 2026-07-01 | Cobo Marc | officer | F | 125 | 7.8 | $975 |
| 2026-07-01 | Elmelech Idan | officer | F | 343 | 7.8 | $2,675 |
| 2026-07-01 | Ben Yong | officer | F | 1,047 | 7.8 | $8,167 |
| 2026-07-01 | Beltran Pedro | director | F | 1,047 | 7.8 | $8,167 |
| 2026-07-01 | Chen Bihua | director | J | 4,528,186 | 0 | $0 |
| 2026-07-01 | Chen Bihua | director | J | 2,692,459 | 0 | $0 |
| 2026-07-01 | Chen Bihua | director | J | 1,704,862 | 0 | $0 |
| 2026-07-01 | Chen Bihua | director | J | 130,865 | 0 | $0 |
| 2026-04-01 | Ben Yong | officer | F | 1,047 | 9.03 | $9,454 |
| 2026-04-01 | Beltran Pedro | director | F | 1,047 | 9.03 | $9,454 |
| 2026-04-01 | Mehra Uneek | other | F | 524 | 9.03 | $4,732 |
| 2026-04-01 | Ben Yong | officer | F | 1,047 | 9.03 | $9,454 |
| 2026-04-01 | Beltran Pedro | director | F | 1,047 | 9.03 | $9,454 |
| 2026-04-01 | Mehra Uneek | other | F | 524 | 9.03 | $4,732 |
| 2026-03-10 | Mehra Uneek | officer | A | 23,330 | 0 | $0 |
| 2026-03-10 | Beltran Pedro | officer | A | 46,670 | 0 | $0 |
| 2026-03-10 | Ben Yong | officer | A | 46,670 | 0 | $0 |
| 2026-03-10 | Mehra Uneek | officer | A | 23,330 | 0 | $0 |
| 2026-03-10 | Beltran Pedro | officer | A | 46,670 | 0 | $0 |
| 2026-03-10 | Ben Yong | officer | A | 46,670 | 0 | $0 |
| 2025-10-10 | BridgeBio Pharma, Inc. | ten percent owner | J | 784,720 | — | — |
| 2025-08-11 | Chen Bihua | director | D | 152,940 | 0 | $0 |
| 2025-08-11 | Chen Bihua | director | M | 4,172,126 | — | — |
| 2025-08-11 | Chen Bihua | director | A | 760,496 | 10.72 | $8,152,517 |
| 2025-08-11 | Chen Bihua | director | A | 284,571 | — | — |
| 2025-08-11 | Chen Bihua | director | A | 1,762,760 | — | — |
| 2025-08-11 | Chen Bihua | director | A | 1,905,046 | — | — |
| 2025-08-11 | Chen Bihua | director | A | 5,598,425 | 10.72 | $60,015,116 |
| 2025-08-11 | Chen Bihua | director | A | 639,110 | 10.72 | $6,851,259 |
| 2025-08-11 | Holman Albert A III | other | M | 30,000 | — | — |
| 2025-08-11 | McKenna Mark C. | other | M | 30,000 | — | — |
| 2025-08-11 | Schmid John P. | other | M | 30,000 | — | — |
| 2025-08-11 | Chen Bihua | director | M | 4,172,126 | — | — |
| 2025-08-11 | Chen Bihua | director | D | 152,940 | 0 | $0 |
| 2025-08-11 | Chen Bihua | director | A | 760,496 | 10.72 | $8,150,464 |
| 2025-08-11 | Chen Bihua | director | A | 639,110 | 10.72 | $6,849,534 |
| 2025-08-11 | Chen Bihua | director | A | 5,598,425 | 10.72 | $60,000,000 |
| 2025-08-11 | Chen Bihua | director | A | 1,905,046 | — | — |
| 2025-08-11 | Chen Bihua | director | A | 1,762,760 | — | — |
| 2025-08-11 | Chen Bihua | director | A | 284,571 | — | — |
| 2025-08-11 | Holman Albert A III | other | M | 30,000 | — | — |
| 2025-08-11 | McKenna Mark C. | other | M | 30,000 | — | — |
| 2025-08-11 | Schmid John P. | other | M | 30,000 | — | — |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.